成都看精索静脉曲张好的医院(成都武侯大道静脉曲张医院) (今日更新中)

The USDA is recalling Jenny Craig Chicken Wrap with Barbecue Sauce frozen meals because the vegetables may be contaminated.SK Food Group, located in Ohio and Nevada, recalled approximately 174,207 pounds of the chicken wrap product because the vegetables in the dish may be contaminated with salmonella and listeria.These meals were shipped to consumers in California, Colorado, Florida, Hawaii, Idaho, Illinois, Maryland, Michigan, North Carolina, Oregon, Pennsylvania and Texas.The frozen meals were produced between October 2017 and October 2018.The following products are subject to recall:? 4.5-oz. plastic packages containing “Jenny Craig Chicken Wrap With BBQ Sauce,” with lot codes WO0096753S10, WO0097880S10, WO0098216S10, WO0098565S10, WO0098923S10, WO0100691S10, WO0100692S10, WO0101746S10, WO0101861S10, WO0102176S10, WO0102469S10, WO0102758S10, WO0103920S10, WO0104247S10, WO0104353S10, WO0104615S10, WO0104995S10, WO0106312, WO0106312S10, WO0106945S10, WO0107556S10, WO0108694S10, WO0108695S10, WO0096753S02, WO0097880S02, WO0098216S02, WO00982416S02, WO0098565S02, WO0098923S02, WO0100691S02, WO0100692S02 and WO0101746S02.The frozen meals have establishment numbers "EST. 45367" or "EST. 20552" stamped on the product centerfold.Consuming foods with salmonella can cause diarrhea, cramps and fever. Eating products containing listeria can cause fever, muscle aches, headache, stiff neck, confusion, loss of balance, convulsions and diarrhea.So far no illnesses have been reported.If you have one of these meals, throw it out. 1624

The Tulsa Health Department will contact any individual or setting deemed at risk for exposure for all confirmed positive COVID-19 cases among Tulsa County residents. The virus spreads primarily through respiratory droplets among individuals within close personal contact (within 6’) for a prolonged period of time (ten minutes or longer). Anyone with concerns about their risk of exposure can contact the Tulsa Health Department at 918-582-9355.The Tulsa Health Department respects those exercising their right for peaceful assembly. Crowds and large gatherings can be a conduit for the transmission of COVID-19, which is spreading in our community. All residents are encouraged to exercise their right to gather and protest safely, which includes wearing a cloth face covering to protect those around you, use hand sanitizer when soap and water are not readily available, practice social distancing, and avoid touching your face. We want to encourage residents to use their voice, but do so safely.Today, we reported an additional 34 cases and three deaths in our community, bringing the cumulative total to 1,057 and 57 respectively. 1144

The US House of Representatives will vote on whether to legalize marijuana across the country in September. This would be the first time a chamber of Congress has ever voted on removing marijuana from the Controlled Substances Act.Cannabis was included as what is called a Schedule I drug under the Controlled Substances Act in 1970. Schedule I drugs are defined as having a high potential for abuse and no medical benefit. Other Schedule I drugs include heroin, LSD, ecstasy and peyote.On Friday, representatives were informed the MORE Act will come up for a vote in the September work period of the House.The MORE Act - Marijuana Opportunity Reinvestment and Expungement Act - will expunge some cannabis records and create grant opportunities for people who have been negatively impacted by the criminalization of marijuana in addition to removing it from its Schedule I classification, according to Politico.Marijuana is already legal in 11 states, despite the federal designation as a Schedule I drug.Senate Majority Leader Mitch McConnell is opposed to the act, and some say the odds of it passing the senate are very slim.Even if the MORE Act passes both chambers of Congress, it would not make sales of marijuana legal. Regulation of marijuana would be left to states to decide how to handle it. 1310

The US Food and Drug Administration approved two cancer treatments, Vitrakvi and Xospata, this week after expedited reviews.Vitrakvi, approved Monday, is "a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker)."The FDA said in a statement that it is the second approved cancer treatment that is based on a tumor biomarker instead of the place in the body where the tumor originated.Vitrakvi will be used for the treatment of solid tumors that have an NTRK (neurotrophic receptor tyrosine kinase) gene fusion that do not have a known resistance mutation, that are not metastatic or where surgical removal is likely to lead to severe morbidity, and that have no alternative treatments or have progressed after treatments.NTRK genes are rare but occur in many types of cancer, the FDA said, such as mammary analogue secretory carcinoma and infantile fibrosarcoma.Xospata tablets, approved Wednesday, are for the "treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation," according to the FDA.Alongside the tablets, the agency also approved a diagnostic to detect the mutation."Approximately 25 to 30 percent of patients with AML have a mutation in the FLT3 gene. These mutations are associated with a particularly aggressive form of the disease and a higher risk of relapse," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in the statement.AML is a rapidly progressing cancer that affects the numbers of normal blood cells and calls for continuous transfusions, the FDA said.Both treatments were granted Priority Review designation.Priority Review, established in 1992, means the FDA aims to review the drug or treatment within six months, opposed to 10 months for a standard review."A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications," the FDA says.Both treatments also received?orphan drug?designation, a status granted to drugs for rare diseases or conditions. 2261

The roaring American economy will probably sink into a recession before President Trump stands for re-election in 2020.At least that's the view of Ray Dalio, the billionaire investor who predicted the 2008 financial crisis."The probability of a recession prior to the next presidential election would be relatively high, 70% or something like that," Dalio said on Wednesday evening during an appearance at the Harvard Kennedy School's Institute of Politics.  471

来源：资阳报